Monod Bio Launches CRP Biosensor on New NovoLISA Platform
September 30, 2024
NovoLISA (de Novo protein-Linked Instantaneous Solution-based Assay) Platform for Life Sciences Research and Diagnostics NovoLISA is a rapid, single-step biosensor assay for research use only applications SEATTLE — Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announced today the [...]
The InVivoStar: Expanding Scientifica’s In Vivo Electrophysiology Range
September 30, 2024
Scientifica is pleased to expand its offerings in the in vivo electrophysiology market with the InVivoStar. The InVivoStar provides a tailored solution for researchers conducting multielectrode in vivo recordings. Based upon the world-renowned PatchStar micromanipulator, the InVivoStar delivers the stability and precision essential for accurate electrode placement and reliable data collection, enabling researchers to achieve consistent, [...]
First CO2 incubator shaker on the market with integrated 180 °C sterilization routine
September 30, 2024
Hamburg -- Expression of complex recombinant proteins, the production of viral vectors in mammalian cells, or the production of bioreactor starter cultures is primarily done in shake flask cultures inside CO2 incubator shakers. A major risk factor for reliable budget- and time-planning of these projects is contamination, especially with viruses or Mycoplasma. “Our new CellXpert® [...]
September 30, 2024
News: To better address the unique needs of lab managers in metallurgy, mining and cement plants with solutions that offer enhanced precision, efficiency and versatility, Thermo Fisher Scientific has launched the Thermo Scientific™ ARL™ X900 XRF Spectrometer. The ARL X900 XRF Spectrometer can analyze more than twenty elements in under one minute, offering exceptional speed and [...]
Bio-Works Technologies Confirms Production Scale Order Worth 2.7 mSEK to Leading Swedish CDMO
September 30, 2024
Today, Bio-Works Technologies AB has confirmed a significant production-scale order valued at 2.7 million SEK from a prominent Contract Development and Manufacturing Organization (CDMO) based in Sweden. This order represents a strong endorsement of Bio-Works’ advanced chromatographic resins used in the purification of biomolecules. The collaboration with the CDMO further solidifies Bio-Works’ position as a [...]
Change of CEO at ZEISS in 2025
September 30, 2024
ZEISS opts for continuity on Executive Board: Andreas Pecher, currently an Executive Board member and responsible for the ZEISS Semiconductor Manufacturing Technology segment, will become the new President and CEO of Carl Zeiss AG effective 1 April 2025. He will succeed Dr. Karl Lamprecht, who has decided not to extend his contract. Dr. Frank Rohmund [...]
September 30, 2024
Depixus’ award-winning MAGNA One instrument enables simultaneous real-time measurement of thousands of individual dynamic biomolecular interactions Revolutionary, user-friendly platform delivers unprecedented insights into biology, empowering researchers to explore disease mechanisms and accelerate drug development Launching at Discovery on Target, Boston, this is the first commercially available instrument of its kind Paris, France – Depixus, a pioneer [...]
September 30, 2024
SCOTTS VALLEY, Calif. -- Dovetail Genomics, a pioneer in Hi-C genomic services, is proud to announce the launch of its Certified Service Provider program. Leveraging over a decade of expertise in running Hi-C services, this program is designed to transfer Dovetail's knowledge to premier service labs around the world. This program provides core labs the tools and [...]
September 29, 2024
Boston, MA – Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance biological modeling. Constructed using low-drug-absorbing plastics, Chip-R1 builds upon the core microfluidic design of Organ-Chips, offering researchers greater precision in predicting human drug responses. In addition [...]
September 27, 2024
Barcelona – Sequentia Biotech, a #deeptech and leading bioinformatics company focused on the analysis and application of omics data, announces a €10million Series A, led by Seventure Partners, a French Venture Capital & Growth investment company with an extensive experience in Life Sciences. The Series A is co-invested by the EIC Fund, the European Commission initiative dedicated to [...]

